Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Porcine GDNF ELISA Kit (AC3471)
Cat.#: ASET-2060
Specifications
Description Porcine GDNF ELISA Kit allows for the in vitro quantitative determination of porcine GDNF concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Porcine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1462 Human Salusin alpha ELISA Kit (AC2873) Quantitative inquiry ASET-1737 Human NCAM1 ELISA Kit (AC3148) Quantitative inquiry ASET-2136 Human 5HT2A Receptor ELISA Kit (AC3547) Quantitative inquiry ASET-2234 Human Cx30 ELISA Kit (AC3645) Quantitative inquiry ASET-1421 Porcine VCAM1 ELISA Kit (AC2832) Quantitative inquiry ASET-1004 Guinea Pig eNOS ELISA Kit (AC2415) Quantitative inquiry ASET-2481 Mouse BDNF ELISA Kit (AC3892) Quantitative inquiry ASET-1672 Human TMPRSS4 ELISA Kit (AC3083) Quantitative inquiry ASET-1307 Rat TNF Receptor II ELISA Kit (AC2718) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket